missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Description
RAGE 229 is an antagonist of the interaction between the cytoplasmic tail of the receptor for advanced glycation end products (ctRAGE) and the formin, Diaphanous-1 (DIAPH1) (KD for binding to ctRAGE = 2 nM). RAGE 229 inhibits the migration of human aortic smooth muscle cells in an in vitro wound healing assay (IC50 = 120 nM). RAGE 229 reduces short- and long-term complications of diabetes in mouse models, without lowering blood glucose concentrations. RAGE 229 also reduces plasma concentrations of TNF-α, IL-6, and CCL2/JE-MCP1 and attenuates inflammatory signaling in diabetic mice.
Greener Choice Claims
- Environmental benefits include:
- Ozone-Safe or Safe for the Ozone Layer

Specifications
Specifications
Chemical Name or Material | N-[4-[7-Cyano-4-(4-morpholinylmethyl)-2-quinolinyl]phenyl]acetamide |
CAS | 2143072-85-7 |
Quantity | 5 mg |
Target | AGER |
Molecular Formula | C23H22N4O2 |
Purity | 0.98 |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Tocris Bioscience™ RAGE 229 >
Spot an opportunity for improvement?Share a Content Correction